Home - Products - Others - Other Targets - Brain Injury Derived Neurotrophic Peptide

Brain Injury Derived Neurotrophic Peptide

CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide( ——— )

Catalog No. M42153 CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Brain Injury Derived Neurotrophic Peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Brain Injury Derived Neurotrophic Peptide
  • Description
    Brain Injury Derived Neurotrophic Peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    148330-12-5
  • Formula Weight
    1387.61
  • Molecular Formula
    C62H102N18O18
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lidamidine

    Lidamidine is an effective antidiarrheal agent that inhibits intestinal secretion, reduces intestinal transit, and inhibits smooth muscle contraction.

  • Erythorbic Acid

    Erythorbic Acid is an antiscorbutic agent.

  • 24-Norursodeoxycholi...

    24-norursodeoxycholic acid is a side chain-shortened C23 homolog of UDCA.It has shown potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.It is a Ursodeoxycholic Acid derivative. It is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice24-norUrsodeoxycholic acid markedly improved liver tests and liver histology and significantly reduced hydroxyproline content and the number of infiltrating neutrophils and proliferating hepatocytes and cholangiocytes.?